Latest Research Development News

Page 1 of 11
Clinuvel has outlined a multi-year expansion from peptide therapeutics into polymers, long-acting injectables, devices and digital health, backed by A$220 million of planned FY2027-FY2030 spending. The strategy comes with a near-term setback: first patient treatment in the CUV107 vitiligo study has been delayed to February 2027.
Victor Sage
Victor Sage
6 Nov 2026
Aurora Labs has moved another step from propulsion development toward commercial production, securing AS9100D certification and its first US engine order while customer enquiries expand. But with only A$1.148 million in cash at quarter-end and 1.5 quarters of funding estimated, the A$6 million raise is central to the next phase.
Victor Sage
Victor Sage
30 Oct 2026
Archer Materials has moved its IonQ relationship into early commercial activity and advanced its Biochip towards external testing, but its graphene spin qubit demonstration is taking longer than expected. The company ended September with $A13.0 million in cash and an estimated 4.68 quarters of funding at its quarterly operating burn.
Victor Sage
Victor Sage
28 Oct 2026
Viridis Mining and Minerals Limited (ASX:VMM) has used its FY2026 annual report to present Colossus as a rare earths project moving from study work into execution. The company has reported strong DFS economics and fresh equity funding, but still needs key permits, binding offtake and senior debt before construction can fully proceed.
Maxwell Dee
Maxwell Dee
28 Sept 2026
Innovaero Technologies is seeking A$40 million through a proposed ASX listing to advance its OWL loitering munition program and expand manufacturing capacity. The replacement prospectus also makes clear that the company remains loss-making and heavily dependent on the Department of Defence converting development work into production orders.
Victor Sage
Victor Sage
18 Sept 2026
Viridis Mining and Minerals has secured approval for a R$77.5 million BNDES financing facility, reducing the estimated senior debt still required for its Colossus rare earth project to about US$280 million. The 16-year facility carries an indicative current cost of approximately 4.8% and supports the project’s Brazilian processing and research infrastructure.
Maxwell Dee
Maxwell Dee
9 Sept 2026
TALi Digital (ASX:TD1) is raising up to $3.3 million through a Security Purchase Plan and Placement to fund its acquisition of Datasphere Analytics and advance its AI-driven education platform.
Sophie Babbage
Sophie Babbage
1 Sept 2026
CleanSpace Holdings is set to repurchase up to 10% of its shares over the next year, signalling confidence in its growth prospects and capital position.
Victor Sage
Victor Sage
28 Aug 2026
TALi Digital is acquiring Datasphere Analytics to access cutting-edge memristive in-memory computing technology, aiming to enhance its AI-driven education platform. The company is concurrently raising $3.3 million to fund this strategic move and ongoing operations.
Sophie Babbage
Sophie Babbage
24 Aug 2026
AoFrio’s revenue fell 21.5% in 1H26, dragged down by a 50.5% plunge in motor sales due to US tariffs, while IoT revenue grew modestly. The company launched new cellular and software platforms, raised NZD 8.9 million, and is expanding into Food Retail, but full-year revenue growth now looks unlikely.
Sophie Babbage
Sophie Babbage
5 Aug 2026
Eagle Mountain Mining and Nittetsu Mining have signed a non-binding MOU to jointly explore new mineral project opportunities in Australia and North America, building on their existing Oracle Ridge joint venture.
Maxwell Dee
Maxwell Dee
21 July 2026
Nexalis Therapeutics has ended funding negotiations with Point8 Capital after failing to secure a formal agreement, while successfully completing its IRX-616a Phase 1 trial with no serious adverse events. The company is reassessing clinical priorities amid funding uncertainty.
Ada Torres
Ada Torres
6 July 2026

Browse the archive

Full archive